Skip to main content
. 2016 Jun 4;7(28):44023–44038. doi: 10.18632/oncotarget.9829

Table 1. Influence of clinical parameter on RFS.

Oropharynx stage III-IV HNSCC stage III IV (TCGA)
HR (CI) p HR (CI) p
Gender 0.83 (0.37 - 1.86) 0.646 0.89 (0.5 - 1.58) 0.716
Age 1 (0.97 - 1.03) 0.901 1 (0.63 - 1.59) 0.998
Stage 2.38 (0.92 - 6.12) 0.073 1.58 (0.91 - 2.75) 0.106
Margin 1.59 (1.14 - 2.23) 0.007 ** 1.54 (1.18 - 2) 0.001**
Alcohol/tobacco 0.8 (0.24 - 2.61) 0.708 1.01 (0.64 - 1.61) 0.963
HPV 0.43 (0.13 - 1.41) 0.165 0.36 (0.05 - 2.74) 0.327
NT5E 0.64 (0.35 - 1.18) 0.151 0.6 (0.38 - 0.94) 0.027*
MiR-422a 1.99 (1.07 - 3.7) 0.030 * 3.03 (0.42 - 21.93) 0.271